Mediq B.V. supplies medical devices, pharmaceuticals, and associated care services. It also offers treatments in the areas of continence, diabetes, infusion therapy, medical nutrition, ostomy, pharmaceuticals, respiration, and wound care. The company provides its services at home, with general practitioners, at hospitals, at care institutions, or at pharmacies to patients, healthcare professionals, and healthcare insurers. It serves customers worldwide. The company was founded in 1899 and is headquartered in Utrecht, the Netherlands with operations in the United States, the Netherlands, Denmark, Germany, Norway, Sweden, Finland, France, Hungary, Switzerland, Belgium, Estonia, Latvia, and Lit...
Utrecht, 3543 AS
Founded in 1899
Mediq B.V. Announce Executive Changes
Dec 16 14
Mediq B.V. has announced the departure of Jesper Boysen, executive vice president, Nordics and Baltics. Joergen Kelkjaer has been appointed as his successor. Jesper Boysen joined Mediq in 2006 and has been EVP Nordics & Baltics since 2009. Joergen Kelkjaer has been Managing Director at Tjellesen Max Jenne (part of Celesio) since 2009.
Mediq BV Appoints Arthur de Bok as New CEO and Chairman of the Management Board, Effective April 1, 2014
Mar 24 14
Mediq BV has announced the appointment of Arthur de Bok as the new CEO and chairman of the management board, effective April 1, 2014. Arthur de Bok has extensive international experience and has held several executive positions at Goodyear Tire & Rubber Company and Procter & Gamble, most recently as President of Goodyear EMEA. Arthur de Bok will use his international business expertise to strengthen Mediq's position as an international service provider in the healthcare market.
Mediq NV(ENXTAM:MEDIQ) dropped from Euronext 150 Index
Mar 17 13
Mediq NV will be removed from the Euronext 150 Index.